THEOPHYLLINE ANHYDROUS powder Združene države Amerike - angleščina - NLM (National Library of Medicine)

theophylline anhydrous powder

attix pharmaceuticals - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 1 kg in 1 kg

THEOPHYLLINE tablet, extended release Združene države Amerike - angleščina - NLM (National Library of Medicine)

theophylline tablet, extended release

physicians total care, inc. - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 100 mg - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE tablet, extended release Združene države Amerike - angleščina - NLM (National Library of Medicine)

theophylline tablet, extended release

alembic pharmaceuticals inc. - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 300 mg - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE tablet, extended release Združene države Amerike - angleščina - NLM (National Library of Medicine)

theophylline tablet, extended release

alembic pharmaceuticals limited - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 300 mg - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE tablet, extended release Združene države Amerike - angleščina - NLM (National Library of Medicine)

theophylline tablet, extended release

state of florida doh central pharmacy - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 300 mg - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE EXTENDED RELEASE- theophylline, anhydrous tablet, extended release Združene države Amerike - angleščina - NLM (National Library of Medicine)

theophylline extended release- theophylline, anhydrous tablet, extended release

ncs healthcare of ky, inc dba vangard labs - theophylline (unii: c137dtr5rg) (theophylline anhydrous - unii:0i55128jyk) - theophylline 300 mg - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE solution Združene države Amerike - angleščina - NLM (National Library of Medicine)

theophylline solution

pai holdings, llc - theophylline (unii: c137dtr5rg) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 80 mg in 15 ml - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline oral solution usp is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEOPHYLLINE EXTENDED RELEASE- theophylline, anhydrous tablet, extended release Združene države Amerike - angleščina - NLM (National Library of Medicine)

theophylline extended release- theophylline, anhydrous tablet, extended release

ncs healthcare of ky, inc dba vangard labs - theophylline (unii: c137dtr5rg) (theophylline anhydrous - unii:0i55128jyk) - theophylline 200 mg - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

ELIXOPHYLLIN - theophylline anhydrous liquid Združene države Amerike - angleščina - NLM (National Library of Medicine)

elixophyllin - theophylline anhydrous liquid

caraco pharma, inc. - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 80 mg in 15 ml - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. elixophyllin elixir is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

THEO-24- theophylline anhydrous capsule, extended release Združene države Amerike - angleščina - NLM (National Library of Medicine)

theo-24- theophylline anhydrous capsule, extended release

endo pharmaceuticals, inc. - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 100 mg - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theo-24 is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.